Skip to main content
Top
Published in: Abdominal Radiology 4/2007

01-08-2007

Diffusion-weighed MR imaging of pancreatic carcinoma

Authors: M. Matsuki, Y. Inada, G. Nakai, F. Tatsugami, M. Tanikake, I. Narabayashi, D. Masuda, Y. Arisaka, K. Takaori, N. Tanigawa

Published in: Abdominal Radiology | Issue 4/2007

Login to get access

Abstract

Purpose

The aim of this study was to demonstrate the feasibility of body diffusion-weighted (DW) MR imaging in the evaluation of a pancreatic carcinoma.

Material and methods

In nine normal volunteers and in eight patients with pancreatic carcinoma, DW images were obtained on the axial plane scanning with a multisection spin-echo-type single-shot echo planar sequence with a body coil. Moreover, we measured the apparent diffusion coefficient (ADC) value in a circular region of interest (ROI) within the normal pancreas, pancreatic carcinoma, and tumor-associated chronic pancreatitis.

Results

On the DW images, all eight carcinomas were clearly shown as high signal intensity relative to the surrounding tissue. The ADC value (×10−3 mm2/s) in the carcinoma was 1.44 ± 0.20, which was significantly lower compared to that of normal pancreas (1.90 ± 0.06) and tumor-associated chronic pancreatitis (2.31 ± 0.18).

Conclusion

Diffusion-weighted (DW) images can be helpful in detecting the pancreatic carcinoma and accessing the extent of the tumor.
Literature
1.
go back to reference Taouli B, Vilgrain V, Dumont E, et al. (2003) Evaluation of liver diffusion isotrophy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 226:71–78PubMedCrossRef Taouli B, Vilgrain V, Dumont E, et al. (2003) Evaluation of liver diffusion isotrophy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 226:71–78PubMedCrossRef
2.
go back to reference Takahara T, Imai Y, Yamashita T, et al. (2004) Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22:275–282PubMed Takahara T, Imai Y, Yamashita T, et al. (2004) Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22:275–282PubMed
3.
go back to reference Ichikawa T, Haradome H, Hachiya J, et al. (1999) Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging 24:456–461PubMedCrossRef Ichikawa T, Haradome H, Hachiya J, et al. (1999) Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging 24:456–461PubMedCrossRef
Metadata
Title
Diffusion-weighed MR imaging of pancreatic carcinoma
Authors
M. Matsuki
Y. Inada
G. Nakai
F. Tatsugami
M. Tanikake
I. Narabayashi
D. Masuda
Y. Arisaka
K. Takaori
N. Tanigawa
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 4/2007
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-007-9192-6

Other articles of this Issue 4/2007

Abdominal Radiology 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine